ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Pretax margin (%)

ABBOTT LABORATORIES (ABT)

Market cap
$154.9B
P/E ratio
24x
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 202519.1+14.24%
Dec 31, 202416.7+0.62%
Dec 31, 202316.6-12.68%
Dec 31, 202219-0.18%
Dec 31, 202119.1+32.79%
Dec 31, 202014.4+12.33%
Dec 31, 201912.8+36.01%
Dec 31, 20189.4+15.35%
Dec 31, 20178.1+20.21%
Dec 31, 20166.8-56.56%
Dec 31, 201515.6+35.19%
Dec 31, 201311.5-13.77%
Dec 31, 201113.4-17.63%
Dec 31, 201016.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat